[Routine urinary examinations. Can test-strip examination substitute for microscopy in routine urinary examinations in internal medicine departments?].
Explore the source record for details and available documents.
Humans↗
Biomedical subjects
P M Mathisen
Publications and source records attributed to P M Mathisen.
Developmental changes in keratin patterns during epidermal maturation.
The biochemical maturation of the epidermis of Xenopus laevis was examined through an identification of the keratins expressed at selected stages of development. The keratin patterns obtained were compared to those observed in the adult epidermis and two Xenopus non-epidermal, epithelial cell lines. The keratins expressed during development can be grouped into three classes: (1) keratins which are restricted to the embryonic epidermis (58 and 59 kDa); (2) keratins which are prominent during development, but become minor components of the adult epidermis (47, 48, and 60 kDa); and (3) keratins which accumulate during development to become the major keratins of the adult epidermis (49, 53, 56, and 63 kDa). The embryo-specific keratins are present at all developmental stages prior to metamorphosis which we have investigated, but disappear when the epidermis keratinizes during metamorphosis. Both class 1 and 2 keratins, while undetectable or minor components of the adult skin, are present in the two non-epidermal cell lines. In contrast, the class 3 keratins show little overlap with the keratins of these cell lines. All of the class 3 keratins appear after hatching with the exception of the 53-kDa keratin which is present at the earliest developmental stage which we have examined. All of the major keratins of the adult epidermis accumulate as metamorphosis proceeds, while the embryo-restricted keratins are gradually lost.
Animals↗
T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification.
Autoreactive CD4+ Th2 cells have been shown to be therapeutic in the treatment of EAE. However, their full therapeutic potential has yet to be realized. Genetic modification of autoreactive Th2 T cells may provide the means for delivering therapeutic transgene factors to autoimmune inflammatory lesions. Optimum therapeutic effects may be achieved by designing Th2 T cells in such a way that expression of transgene factors is regulated by antigen-inducible IL4, IL5 or IL10 transgene promoters. The innate antiinflammatory effects of the native autoreactive Th2 T cell may be enhanced by incorporating transgene regenerative growth factors in the T-cell design. Such factors may include remyelination growth factors (PDGF-A, bFGF, and IGF-I) that complement each other by acting predominantly at different stages in the development of mature myelinating oligodendrocytes. Moreover, in light of recent findings indicating extensive axonal damage during MS, neuroprotective transgene factors may prove to be therapeutic when delivered to EAE lesions by autoreactive Th2 T cells. Thus, optimum therapeutic effects may require multiple transfers of autoreactive Th2 T cells producing several distinct complementary transgene factors. In addition, the pathogenicity of epitope spreading and the inherent instability of self recognition during EAE may require serial transfer of genetically modified T cells reacting to multiple self determinants.
Animals↗